Trump Hosts RFK Jr. And Pharma Leaders To Discuss Healthcare Reform
President-elect Donald Trump recently hosted a dinner at Mar-a-Lago with Robert F. Kennedy Jr. and pharmaceutical executives to discuss healthcare priorities. Pfizer CEO Albert Bourla, Eli Lilly CEO David Ricks, and PhRMA leader Steve Ubl were among the attendees.
Kennedy, a longtime critic of the pharmaceutical industry, has been outspoken about the dangers posed by unchecked corporate power. His selection as Health and Human Services Secretary signals an administration intent on addressing public concerns about rising drug prices and industry practices.
The dinner centered on how public-private partnerships could advance cancer research and healthcare reform. While the pharmaceutical sector has faced criticism for high costs, its role in innovation was a key topic of the evening’s discussions.
Trump’s healthcare agenda includes addressing drug pricing and improving access to treatments. Kennedy’s inclusion in the conversation reflects the administration’s effort to balance collaboration with scrutiny of the industry.
Dr. Mehmet Oz, Trump’s nominee for Medicare and Medicaid Services, also attended the dinner. The discussions reportedly covered healthcare challenges and the steps necessary to deliver on Trump’s vision for reform.
By bringing together Kennedy’s critical perspective and the expertise of pharmaceutical executives, Trump’s team is shaping a healthcare strategy that seeks to protect Americans while fostering medical innovation.
